Possibilities of Implementing Hospital-Based Health Technology Assessment (HB-HTA) at the Level of Voivodeship Offices in Poland

Int J Environ Res Public Health. 2022 Sep 7;19(18):11235. doi: 10.3390/ijerph191811235.

Abstract

The Health Technology Assessment is based on the evaluation of the characteristics and effects of health technologies to properly spend resources in healthcare. For the needs of hospitals, a special HTA department, Hospital-Based Health Technology Assessment (HB-HTA), has been established. The objective of the article is to assess the possibility of implementing a functional model with the coordinating role of Health Departments of the Voivodeship Offices with the support of the National Health Fund and the HTA Agency in Poland. Ten semi-structured interviews were conducted with representatives from eight Voivodeship Offices. The interviews consisted of nine questions related to the possibility of introducing a functional model with the participation of the Voivodeship Office. The material was divided into seven codes relating to the questions included in the topic guide. From the perspective of Voivodeship Offices, HB-HTA could contribute to the improvement of the methodology used in the Evaluation Instrument of Investment Motions in Health. The lack of personnel in the Voivodeship Offices was identified as one of the greatest barriers to the implementation of HB-HTA. These public administration units should not be involved in the hospital health technology assessment process.

Keywords: HB-HTA; Voivodeship Office; medical technology; semi-structured interviews.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Delivery of Health Care
  • Hospitals*
  • Poland
  • Technology Assessment, Biomedical*

Grants and funding

This study was financed by the project entitled “Implementation of Hospital Assessment of Innovative Medical Technologies”, financed under the grant from the National Center for Research and Development (project number: 1/395107/18/NCBR/2018), led by the consortium of the National Health Fund, the National Institute of Cardiology, and the Lazarski University.